Why can some G6PD variants make red blood cells more vulnerable to oxidative stress?
A gene, an enzyme, a pathway, and a redox cycle meet in one cell-specific mechanism.
The gene encodes an enzyme; the enzyme catalyzes a pathway reaction.
NADPH supplies reducing power; it does not destroy peroxides by itself.
GPX1 is one part of a broader antioxidant network.
The pathway changes susceptibility; it is not a deterministic forecast for a person.
Infection, medicines, and other oxidant exposures differ; this is not a personal medication-risk tool.
This is a selected mechanism, not a complete red-cell redox network. The oxidative pentose-phosphate branch makes NADPH through both G6PD and 6-phosphogluconate dehydrogenase. G6PD variants differ, and an oxidative challenge does not cause hemolysis in every person or every exposure.
Mature red blood cells have no mitochondria. They use glycolysis to make ATP and rely on the pentose phosphate pathway for NADPH, which helps maintain antioxidant defenses. Some G6PD variants reduce enzyme activity, so a red cell may have less capacity to respond to particular oxidant challenges.
The G6PD gene encodes glucose-6-phosphate dehydrogenase. Different variants can leave different amounts of enzyme activity; the gene name alone does not predict severity.
G6PD catalyzes the first oxidative reaction of the pentose phosphate pathway. Together, the two oxidative dehydrogenase reactions produce NADPH.
NADPH powers glutathione reductase, which recycles oxidized glutathione (GSSG) into reduced glutathione (GSH).
Glutathione peroxidase can use GSH to reduce hydrogen peroxide to water, converting GSH back to GSSG.
If an oxidant challenge exceeds a susceptible red cell's defenses, oxidative damage and hemolysis can occur. Whether and how severely this happens depends on variant, residual activity, cell age, exposure, and other context.
Each biological link has its own source trail and a qualification describing the context in which it applies.
Study scopeOxidative challenge; triggers and response vary by genotype and individual context.
The human G6PD gene encodes glucose-6-phosphate dehydrogenase.
Study scopeOxidative challenge; triggers and response vary by genotype and individual context.
Context and qualificationNCBI annotates G6PD as a protein-coding gene and lists multiple transcript/protein isoforms.
G6PD catalyzes the first oxidative reaction of the pentose phosphate pathway, reducing NADP+ as glucose 6-phosphate is oxidized.
Study scopeOxidative challenge; triggers and response vary by genotype and individual context.
Context and qualificationThis is the pathway entry reaction; 6-phosphogluconate dehydrogenase also generates NADPH later in the oxidative branch.
G6PD catalyzes the pentose-phosphate pathway's entry reaction, oxidizing glucose 6-phosphate while reducing NADP+ to NADPH.
Study scopeOxidative challenge; triggers and response vary by genotype and individual context.
Context and qualificationThis is a selected human teaching reaction from the oxidative branch. It is not a complete representation of pathway flux or every cellular context.
The oxidative branch of the human pentose phosphate pathway generates NADPH.
Study scopeOxidative challenge; triggers and response vary by genotype and individual context.
Context and qualificationThe two oxidative dehydrogenase reactions contribute NADPH; the pathway also supplies pentose-phosphate intermediates, and net flux depends on cellular demand.
Mature human red blood cells lack mitochondria and rely on the pentose phosphate pathway for NADPH production.
Study scopeOxidative challenge; triggers and response vary by genotype and individual context.
Context and qualificationThis statement is scoped to mature erythrocytes; it should not be generalized to nucleated cells or other tissues.
NADPH powers glutathione reductase to convert oxidized glutathione (GSSG) back to reduced glutathione (GSH).
Study scopeOxidative challenge; triggers and response vary by genotype and individual context.
Context and qualificationGSH is one part of red-cell antioxidant defense; this simplified chain does not represent every peroxide-removal or redox system.
GPX1 can use GSH to reduce hydrogen peroxide to water, producing GSSG.
Study scopeOxidative challenge; triggers and response vary by genotype and individual context.
Context and qualificationGPX1 is one contributor; other antioxidant enzymes and context-specific redox processes also matter.
Some G6PD variants reduce enzyme activity and can leave erythrocytes less able to replenish NADPH during an oxidative challenge.
Study scopeOxidative challenge; triggers and response vary by genotype and individual context.
Context and qualificationResidual activity, variant, erythrocyte age, sex and X-chromosome inactivation, exposure, and other biology affect phenotype; this is not a deterministic individual prediction.
Some people with G6PD deficiency can develop acute hemolysis after particular infections or oxidant exposures, including some medications.
Study scopeOxidative challenge; triggers and response vary by genotype and individual context.
Context and qualificationRisk differs by drug, dose, genotype, residual enzyme activity, co-exposures, and clinical state. BASE does not classify a user's medication as safe or unsafe or predict personal risk.
Mature red cells lack mitochondria and depend on the pentose phosphate pathway for NADPH. NADPH helps recycle glutathione used in antioxidant reactions.
No. Residual enzyme activity, variant, red-cell age, sex and X-chromosome inactivation, the exposure, and other clinical context affect risk. This map cannot predict an individual's response.
Glutathione disulfide (GSSG) is reduced back to reduced glutathione (GSH).